L1CAM and neoplasm: So far, the only clinical application of L1CAM in patients consisted in the use of a radioactively labeled antibody as an imaging tool to detect neuroblastoma, a study that pointed to L1CAM as a suitable target for radioimmunotherapy of that tumor type [87].